Lab Test and Tumor Markers in SSF Objective 7/13/2010. Part I Section 2: Site Specific Notes

Size: px
Start display at page:

Download "Lab Test and Tumor Markers in SSF Objective 7/13/2010. Part I Section 2: Site Specific Notes"

Transcription

1 LAB TESTS AND TUMOR MARKERS Part I Section 2: Site Specific Notes 2 Lab Test and Tumor Markers in SSF Objective To review and understand: Where and what to look for lab test results What does SI mean Prefixes and abbreviation Common Codes in Site Specific Factors Tumor Markers to site or histology specific schemas 3 1

2 Recording lab test and Tumor Markers Guide to registrars how to code lab test results Lab test should be coded in the CS SSFs Tumor markers and laboratory test may vary according to the lab and/or manufacturer When ever possible code the clinician s or pathologist s interpretations of the lab test In the absence of a doctor s interpretation of the test, if the reference range is available use this information to assign the code 4 Recording lab test and Tumor Markers Only when there is no clinician/pathologist interpretation of the lab test and no description of the reference range in the medical record should the registrar use background information listed in the tumor marker notes to code the SSF 5 Recording lab test and Tumor Markers Refer to the CS Manual for allowable codes Refer to the CS Manual for additional coding choices when the test results are not in the Medical Record 6 2

3 Lab Tests & Tumor Markers What does SI mean? French abbreviation for International System for standard units of measure Most SI values are based on kilogram, liter, or standard unit of time (seconds) A nanogram (ng) is one thousandth of a microgram (μg) A milliliter (ml) is one thousandth of a liter 7 Lab Tests & Tumor Markers What does SI mean? Lab value expressed in μg/l is equivalent to the same value expressed in ng/ml Some lab values, such as hormone levels, are recorded in International Units per Liter (IU/L) This is equivalent to miu/ml The equivalence of miu to ng varies according to what is measured SI Conversion: 1 μg/l = 1 ng/ml. For example, 1 ng of AFP is approximately equal to 1 miu Micrograms (μg) per liter may be shown as ug/l 8 urement_files/image021.jpg 3

4 Lab Tests & Tumor Markers Prefixes and abbreviations Units of Measure described and written in various ways in the medical record Unit of Measure dependent on the printer used to report Prefix micron (one millionth of a unit) scientific notation by the Greek Letter mu(μ) 10 Abbreviations for units of measurement Number Prefix Written 1,000,000 Mega M 1000 Kilo k 10 Deka da 1 (baseline) 1/10 Deci d 1/100 Centi c 1/1000 Milli m One millionth Micro m, u, or mc One billionth Nano n One trillionth Pico p One quadrillionth Femto f 11 Abbreviations for units of measurement Unit Abbrev Gram: gr Liter : L, l Unit : U Meter: M milli Equivalent meq Unit of substance: Mole, mol Examples Femtomole : fmol Microgram: ugr mcg μgr Milliliter : ml, ml 12 4

5 Common Codes in SSF Numeric Site Specific factor : Code 000 CEA, Chromogranin, CA 125, means a zero value on the test itself Code 979 (depending on the test) = 97.9 Code 980 Means that the true value was higher Code 988 Test was not performed (Remember Do not assume test was done Code 997 Ordered but no report in the MR Code 999 No information in the MR about the lab value 13 CA 19 9 Lab Value Appears in Schema: Stomach, Appendix, Ampulla of vater, Intraheptatic bile ducts, perihilar bile duct, Distal bile duct, all subsites of pancreas Normal reference range <37 U/mL FCDS & CoC Not Required in SSF s 14 CA 19 9 Lab Value Note 1: Carbohydrate Antigen 19 9 is a tumor marker that has value in the management of certain malignancies. Note 2: Record in Units/milliliter the highest CA 19 9 lab value recorded in the medical record prior to treatment. Example: A pretreatment CA 19 9 of 60 Units/milliliter (U/ml) would be recorded as

6

7 CEA (CARCINOEMBRYONIC ANTIGEN) Normal reference range Used in schemas: Stomach; Small Nonsmoker: < 2.5 ng/ml (SI: < intestine; Appendix carcinoma; 2.5 μg/l) Colon; Rectum; Ampulla of Vater; Perihilar bile ducts; Distal bile SI Conversion: 1 μg/l = 1 ducts; Ampulla of Vater ng/ml. Smoker: < 5 ng/ml (SI: < 5 Source documents: clinical lab μg/l) 1 μg/ml = 1 mg/l report, sometimes pathology or cytology report; H&P, operative report; consultant report; Ex: Colon/Rectal/Appendix SSF 1 Discharge summary FCDS NOT required CoC required 19 CEA (CARCINOEMBRYONIC ANTIGEN) Record both the reported value and the clinician s interpretation of the highest value prior to treatment. Code in nanograms per milliliter (ng/ml) the highest preoperative CEA lab value documented. If multiple CEA tests were performed prior to treatment, record the highest value. CEA Interpretation Code the corresponding interpretation of the CEA lab value as stated by the clinician. Use code 000 if there is a statement in the record that If there is no statement that the CEA is positive/elevated, ii negative/normal or the like, code the interpretation as Positive/elevated 020 Negative/normal 030 Borderline; undetermined whether positive or negative Notes: CEA is not a screening test and is not specific to colorectal cancer. Unlikely to be benign if > 10 ng/ml. Distant metastasis most likely if >100 ng/ml. 20 CHROMOGRANIN A (CGA) SSF 3 digit field implied decimal point Protein released by neuroendocrine cells Appears in Schemas: Pancreas (endocrine, all subsites); Neuroendocrine tumors Stomach; Small intestine; Appendix; Colon; Rectum; Ampulla of Vater Source documents: pathology report (immunohistochemistry stain) or clinical lab report (blood serum) Other names: Serum chromogranin A, CGA, chromogranin Chromagranin A is positive more often for WD NET (Carcinoid) than PD Record the higest CgA value prior to treatment Normal reference range Path report: Positive/negative Lab: ng/ml Results vary by laboratory Ex: NET Ampulla SSF 5 FCDS NOT required CoC required 21 7

8 HPV (HUMAN PAPILLOMA VIRUS) STATUS Appears in Schemas: All head and neck sites (carcinoma and melanoma) except major salivary glands and Other Pharynx ; Anus; Penis Source documents: pathology report (immunohistochemical staining), molecular analysis FCDS & CoC Not Required in SSF s Other names: human papillomavirus, HPV, HPV DNA test, human papillomavirus in situ hybridization, HPV hybrid capture test; high risk types: hr HPV, HRHPV 22 LDH, LDH VALUE, LDH UPPER LIMIT OF NORMAL Appears in Schemas: Melanoma Skin, Testis, Lymphoma Ocular Adnexa Source documents: clinical laboratory report; may be included in a liver or hepatic panel/profile, a cardiac panel, or a general metabolic panel of tests Other names: LD, Lactate dehydrogenase, lactase dehydrogenase, lactic acid dehydrogenase Normal reference range varies widely by laboratory, patient age, and the units of measurement Examples of reference range lab values: Lab A Total LDH U/L Lab B Total LDH U/L Lab C Total LDH U/L Lab D Total LDH U/L 23 LDH (MelanomaSkin)& Preorchiectomy LDH Interpretation (Testis) Melanoma Skin Testis Description Test not done; test not ordered and not performed Within normal limits Range 1: less than 1.5 times the upper limit of normal for that lab; for melanoma only: stated as elevated, NOS Range 2: 1.5 to 10 times the upper limit of normal for that lab Range 3: more than 10 times the upper limit of normal for that lab Test ordered, but results not in chart See schema for additional code choices Melanoma skin SSF 4 Required by FCDS & CoC Testis SSF 10 Preorchiectomy LDH Interpretation Required by FCDS & CoC 24 8

9 LDH (Melanoma Skin) SSF4 For melanoma, an abnormal value (SSF4 codes ) MUST be documented by at least two separate tests obtained more than 24 hours apart, according to the AJCC Cancer Staging Manual Note: LDH may not be done for early stage melanomas. If so, code as

10 MITOTIC COUNT Appears in Schemas: FCDS & CoC Required GIST Appendix GIST Colon GIST Esophagus GIST Peritoneum GIST Rectum GIST Small Intestine GIST Stomach Melanoma Skin FCDS & CoC NOT Required NET Ampulla NET Colon NET Small Intestine NET Stomach NET Rectum Pancreas Head, Pancreas Body Tail, Pancreas Other Source documents: pathology report Other names: Mitotic rate, mitotic index (a ratio do not record this measurement), mitotic activity CoC Required Melanoma Choroid Melanoma Ciliary Body Melanoma Iris 28 Record the number of cells actively dividing as determined by the Pathologist The Count will vary according o the type of tumor Follow the Instructions in the SSF notes NET (ampulla, colon, rectum, small intestine, stomach): count per 10 high power fields (HPF*) or 2 square millimeters GIST (appendix, colon, esophagus, peritoneum, rectum, small intestine, stomach): count per 50 HPF* or 5 square millimeters Melanoma of skin: count per square millimeter Ocular melanoma (choroids, ciliary body, iris): count per 40 HPF* or 4 square millimeters * The usual high power is 40x magnification 29 This site specific factor is a three digit field with an implied decimal point between the second and third digits For example: Mitotic count is reported as.8 mitoses per 50 HPF for a GIST Colon tumor, record as 008 Mitotic rate is reported as 11 mitoses per 50 HPF for a GIST Colon, record as

11 31 32 Reference Collaborative Stage Data Collection System Coding Manual and Instructions Part I Section 2: Site Specific Notes VERSION INCORPORATING UPDATES THROUGH JANUARY 1,

LAB TESTS AND TUMOR MARKERS Part I Section 2: Site Specific Notes

LAB TESTS AND TUMOR MARKERS Part I Section 2: Site Specific Notes LAB TESTS AND TUMOR MARKERS Part I Section 2: Site Specific Notes 2 Lab Test and Tumor Markers in SSF Objective To review and understand: Where and what to look for lab test results What does SI mean Prefixes

More information

COLLABORATIVE STAGE DATA COLLECTION SYSTEM USER DOCUMENTATION AND CODING INSTRUCTIONS

COLLABORATIVE STAGE DATA COLLECTION SYSTEM USER DOCUMENTATION AND CODING INSTRUCTIONS COLLABORATIVE STAGE DATA COLLECTION SYSTEM USER DOCUMENTATION AND CODING INSTRUCTIONS Collaborative Stage Work Group of the American Joint Committee on Cancer Part I General Instructions Version 02.03.02

More information

Gastrointestinal Stromal Tumors (GIST)

Gastrointestinal Stromal Tumors (GIST) Collaborative Stage Version 2: GISTs and NETs Education and Training Team Collaborative Stage Data Collection System Version 2.02 Gastrointestinal Stromal Tumors (GIST) What are GISTs? Rare type of soft

More information

CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I

CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I Changes and Clarifications 16 th Edition April 15, 2016 Quick Look- Updates to Volume

More information

2010 Update. NAACCR Webinar Series 1 4/1/2010. Agenda. Access to 2010 Information. CSv2. Collecting Cancer Data: Soft Tissue Sarcoma

2010 Update. NAACCR Webinar Series 1 4/1/2010. Agenda. Access to 2010 Information. CSv2. Collecting Cancer Data: Soft Tissue Sarcoma NAACCR 2009 2010 Webinar Series Collecting Cancer Data: Soft Tissue Sarcoma, Neuroendocrine Tumors (NET) and Gastrointestinal Stromal Tumors (GIST) Agenda Updates Soft Tissue Sarcoma Overview CSv2 MP/H

More information

Getting Specific About Site-Specific Factors

Getting Specific About Site-Specific Factors Getting Specific About Site-Specific Factors CS version 0203 Education and Training Team Overview CSv0202 to CSv0203 changes What are Site-Specific Factors? Types of Site-Specific Factors Examples Code

More information

Collaborative Stage Data Collection System (CSv2) Reporting Requirements Commission on Cancer (CoC) (Updated 4/8/ changes in red print)

Collaborative Stage Data Collection System (CSv2) Reporting Requirements Commission on Cancer (CoC) (Updated 4/8/ changes in red print) Collaborative Stage Data Collection System (CSv2) Reporting Requirements Commission on Cancer (CoC) (Updated 4/8/2010 - changes in red print) Timing. Collaborative Stage version 2 must be used for all

More information

Collaborative Stage Data Collection System (CSv xx) Reporting Requirements Commission on Cancer (CoC)

Collaborative Stage Data Collection System (CSv xx) Reporting Requirements Commission on Cancer (CoC) Collaborative Stage Data Collection System (CSv 02.03.xx) Reporting Requirements Commission on Cancer (CoC) Timing. Collaborative Stage version 02.03.xx must be used for all cases diagnosed on or after

More information

Kyle L. Ziegler, CTR. California Cancer Registry U.C. Davis Health System

Kyle L. Ziegler, CTR. California Cancer Registry U.C. Davis Health System Kyle L. Ziegler, CTR California Cancer Registry U.C. Davis Health System Overview New Data Items Reportability Clarifications New Coding Rules Grade ICD-O-3 Changes Collaborative Stage v0205 2 New Data

More information

There is a Reason for Everything including Changes

There is a Reason for Everything including Changes There is a Reason for Everything including Changes What & Why Who & When Overview A Closer look Introduction & Overview of Site-Specific Data Items A.K.A. SSDIs Let me introduce myself Colleen M. Grosso,

More information

Collecting Cancer Data: GIST/NET 1/9/14

Collecting Cancer Data: GIST/NET 1/9/14 Collecting Cancer Data: Gastrointestinal Stromal Tumor (GIST) Gastrointestinal Neuroendocrine Tumors (NET) 2013 2014 NAACCR Webinar Series January 9, 2014 Q&A Please submit all questions concerning webinar

More information

Q&A Session NAACCR Webinar Series Collecting Cancer Data: Pancreas January 05, 2012

Q&A Session NAACCR Webinar Series Collecting Cancer Data: Pancreas January 05, 2012 Q&A Session NAACCR Webinar Series Collecting Cancer Data: Pancreas January 05, 2012 Q: Will sticky notes be transferrable from the previous electronic version of CS to the updated version? A: It is our

More information

Collecting Cancer Data: Pancreas

Collecting Cancer Data: Pancreas Collecting Cancer Data: Pancreas NAACCR 2011 2012 Webinar Series 1/5/2012 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this

More information

MCR: MANAGEMENT OF 2018 CHANGES. By: Maricarmen Traverso-Ortiz MPH, CGG, CTR

MCR: MANAGEMENT OF 2018 CHANGES. By: Maricarmen Traverso-Ortiz MPH, CGG, CTR MCR: MANAGEMENT OF 2018 CHANGES By: Maricarmen Traverso-Ortiz MPH, CGG, CTR LEARNING OBJECTIVES Discuss a summary of the new changes for 2018 Overview of how the Maryland Cancer Registry is managing and

More information

NAACCR Webinar Series 1. Instructors Q&A 10/6/2011. Collecting Cancer Data: Larynx Including Mucosal Melanoma of Larynx.

NAACCR Webinar Series 1. Instructors Q&A 10/6/2011. Collecting Cancer Data: Larynx Including Mucosal Melanoma of Larynx. NAACCR 2011 2012 Webinar Series Collecting Cancer Data: Larynx Instructors Shannon Vann, CTR Jim Hofferkamp, CTR 2 Q&A Please submit all questions concerning webinar content through the Q&A panel. 3 NAACCR

More information

CEA (CARCINOEMBRYONIC ANTIGEN)

CEA (CARCINOEMBRYONIC ANTIGEN) (CARCINOEMBRYONIC ANTIGEN) 428 C15.3 Malignant neoplasm of upper third of esophagus C15.4 Malignant neoplasm of middle third of esophagus C15.5 Malignant neoplasm of lower third of esophagus C15.8 Malignant

More information

AJCC 7th Edition Handbook Errata as of 9/21/10

AJCC 7th Edition Handbook Errata as of 9/21/10 5 81 Larynx ICD-O-3 Topography Codes Delete C32.3 Laryngeal cartilage 5 81 Larynx ICD-O-3 Topography Codes Add an asterisk after C32.8 5 81 Larynx ICD-O-3 Topography Codes Add an asterisk after C32.9 5

More information

Site-Specific Data Item (SSDI) Manual

Site-Specific Data Item (SSDI) Manual Site-Specific Data Item (SSDI) Manual Effective with Cases Diagnosed 1/1/2018 and Forward Published May 2018 Editors: Jennifer Ruhl, MSHCA, RHIT, CCS, CTR, NCI SEER Jim Hofferkamp, CTR, NAACCR Elizabeth

More information

SEER Advanced Topic 2018 Presentation. EOD 2018 and SS2018 Jennifer Ruhl

SEER Advanced Topic 2018 Presentation. EOD 2018 and SS2018 Jennifer Ruhl SEER Advanced Topic 2018 Presentation EOD 2018 and SS2018 Jennifer Ruhl May 25, 2018 Outline General overview of EOD Schemas Basic review of what is needed to collect Primary Tumor, Regional Nodes and

More information

SEER EOD AND SUMMARY STAGE ABSTRACTORS TRAINING

SEER EOD AND SUMMARY STAGE ABSTRACTORS TRAINING SEER EOD AND SUMMARY STAGE ABSTRACTORS TRAINING OVERVIEW What is SEER EOD Ambiguous Terminology General Guidelines EOD Primary Tumor EOD Regional Nodes EOD Mets Site Specific Data Items (SSDI) SEER Summary

More information

Carcinoembryonic Antigen

Carcinoembryonic Antigen Other Names/Abbreviations CEA 190.26 - Carcinoembryonic Antigen Carcinoembryonic antigen (CEA) is a protein polysaccharide found in some carcinomas. It is effective as a biochemical marker for monitoring

More information

BIO 137 Human Anatomy & Physiology I. Laboratory Manual. Laboratory #1: Measurements, Body Organization and Anatomical Systems

BIO 137 Human Anatomy & Physiology I. Laboratory Manual. Laboratory #1: Measurements, Body Organization and Anatomical Systems BIO 137 Human Anatomy & Physiology I Laboratory Manual Laboratory #1: Measurements, Body Organization and Anatomical Systems Lab Exercise 1 Measurements Body Organization Body Systems What you need to

More information

Site-Specific Data Item (SSDI) Manual

Site-Specific Data Item (SSDI) Manual Site-Specific Data Item (SSDI) Manual Effective with Cases Diagnosed 1/1/2018 and Forward published April 2018 Editors: Jennifer Ruhl, MSHCA, RHIT, CCS, CTR, NCI SEER Jim Hofferkamp, CTR, NAACCR Elizabeth

More information

Version 2 Overview and Update CSv0202 to CSv0203

Version 2 Overview and Update CSv0202 to CSv0203 Version 2 Overview and Update CSv0202 to CSv0203 CS version 2 Education and Training Team What We ll Cover Rules changes and revisions CSv0202 to CSv0203 Sites with Major Changes Esophagus and Stomach

More information

1 Size of Lymph Nodes Required 3883 LN Size 2. OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck

1 Size of Lymph Nodes Required 3883 LN Size 2. OBSOLETE - Extracapsular Extension, Lymph Nodes for Head and Neck 1 Size of Lymph Nodes Required 3883 LN Size 2 OBSOLETE - Extracapsular Extension, Lymph 3 Levels I-III, Lymph 3-7 Buccal Mucosa, Gum (3), Lip (3), Levels IV-V and Retropharyngeal Lymph Nodes Floor Mouth,

More information

ANNUAL CANCER REGISTRY REPORT-2005

ANNUAL CANCER REGISTRY REPORT-2005 ANNUAL CANCER REGISTRY REPORT-25 CANCER STATISTICS Distribution of neoplasms Of a total of 3,115 new neoplasms diagnosed or treated at the Hospital from January 25 to December, 25, 1,473 were seen in males

More information

Tumour Markers. For these reasons, only a handful of tumour markers are commonly used by most doctors.

Tumour Markers. For these reasons, only a handful of tumour markers are commonly used by most doctors. Tumour Markers What are Tumour Markers? Tumour markers are substances that can be found in the body when cancer is present. They are usually found in the blood or urine. They can be products of cancer

More information

Site-Specific Data Item (SSDI) Manual

Site-Specific Data Item (SSDI) Manual Site-Specific Data Item (SSDI) Manual Effective with Cases Diagnosed 1/1/2018 and Forward DRAFT published February 2018 Editors: Jennifer Ruhl, MSHCA, RHIT, CCS, CTR, NCI SEER Jim Hofferkamp, CTR, NAACCR

More information

4/10/2018. SEER EOD and Summary Stage. Overview KCR 2018 SPRING TRAINING. What is SEER EOD? Ambiguous Terminology General Guidelines

4/10/2018. SEER EOD and Summary Stage. Overview KCR 2018 SPRING TRAINING. What is SEER EOD? Ambiguous Terminology General Guidelines SEER EOD and Summary Stage KCR 2018 SPRING TRAINING Overview What is SEER EOD Ambiguous Terminology General Guidelines EOD Primary Tumor EOD Regional Nodes EOD Mets SEER Summary Stage 2018 Site Specific

More information

Lab Exercise 1. Getting Started with the Basics

Lab Exercise 1. Getting Started with the Basics Anatomy & Physiology Names:, Period date: Textbook Reference: See Chapter 1 Lab Exercise 1. Getting Started with the Basics Measurement Body Organization Body Systems What you need to be able to do to

More information

CODING PRIMARY SITE. Nadya Dimitrova

CODING PRIMARY SITE. Nadya Dimitrova CODING PRIMARY SITE Nadya Dimitrova OUTLINE What is coding and why do we need it? ICD-10 and ICD-O ICD-O-3 Topography coding rules ICD-O-3 online WHAT IS CODING AND WHY DO WE NEED IT? Coding: to assign

More information

2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill

2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill Number of New Cancers Truman Medical Center Hospital Hill Cancer Registry 2015 Statistical Summary Incidence In 2015, Truman Medical Center diagnosed and/or treated 406 new cancer cases. Four patients

More information

Accuracy of the SEER HPV status site specific factor 10 (SSF-10) variable for head and neck cancer (HNC) cases in Iowa:

Accuracy of the SEER HPV status site specific factor 10 (SSF-10) variable for head and neck cancer (HNC) cases in Iowa: Accuracy of the SEER HPV status site specific factor 10 (SSF-10) variable for head and neck cancer (HNC) cases in Iowa: 2010-2014 Amanda Kahl, MPH Mary Charlton, PhD, Nitin Pagedar, MD, MPH, Steven Sperry,

More information

Tumor Markers Yesterday, Today & Tomorrow. Steven E. Zimmerman M.D. Vice President & Chief Medical Director

Tumor Markers Yesterday, Today & Tomorrow. Steven E. Zimmerman M.D. Vice President & Chief Medical Director Tumor Markers Yesterday, Today & Tomorrow Steven E. Zimmerman M.D. Vice President & Chief Medical Director Tumor Marker - Definition Substances produced by cancer cells or other cells in response to cancer

More information

Outcomes Report: Accountability Measures and Quality Improvements

Outcomes Report: Accountability Measures and Quality Improvements Outcomes Report: Accountability Measures and Quality Improvements The FH Memorial Medical Center s Cancer Committee ensures that patients with cancer are treated according to the nationally accepted measures.

More information

I.2 CNExT This section was software specific and deleted in 2008.

I.2 CNExT This section was software specific and deleted in 2008. CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES FOR HOSPITALS California Cancer Reporting System Standards, Volume I Changes and Clarifications 8th th Edition Revised May 2008 SECTION

More information

What s New for 8 th Edition

What s New for 8 th Edition What s New for 8 th Edition KCR 2018 SPRING TRAINING Overview What s New New Chapters for 8 th Editions Chapters That Split in 8 th Edition Merged 8 th Edition Chapters Blanks vs Xs How to Navigate Through

More information

We re on the Web! Visit us at VOLUME 19 ISSUE 1. January 2015

We re on the Web! Visit us at   VOLUME 19 ISSUE 1. January 2015 VOLUME 19 ISSUE 1 January 2015 We re on the Web! Visit us at www.kumc.edu/kcr January is National Cervical Cancer Screening Month. Cervical cancer begins in the lining of the cervix (organ connecting the

More information

Colon and Rectum: 2018 Solid Tumor Rules

Colon and Rectum: 2018 Solid Tumor Rules 2018 SEER Solid Tumor Manual 2018 KCR SPRING TRAINING Colon and Rectum: 2018 Solid Tumor Rules 1 Colon and Rectum Solid Tumor Rules Separate sections for: Introduction Changes from 2007 MP/H rules Equivalent

More information

Quiz 1. Assign Race 1, Race 2 and Spanish Hispanic Origin to the following scenarios.

Quiz 1. Assign Race 1, Race 2 and Spanish Hispanic Origin to the following scenarios. Quiz 1 Assign Race 1, Race 2 and Spanish Hispanic Origin to the following scenarios. 1. 62 year old Brazilian female Race 1 Race 2 Spanish/Hispanic Origin 2. 43 year old Asian male born in Japan Race 1

More information

Case Scenario 1. Discharge Summary

Case Scenario 1. Discharge Summary Case Scenario 1 Discharge Summary A 69-year-old woman was on vacation and noted that she was becoming jaundiced. Two months prior to leaving on that trip, she had had a workup that included an abdominal

More information

Format Of ICD-O Terms In Numerical List Each topographic and morphologic term appears only once The first listed term in Bold Type is the Preferred Te

Format Of ICD-O Terms In Numerical List Each topographic and morphologic term appears only once The first listed term in Bold Type is the Preferred Te Florida Cancer Data System International Classification of Diseases for Oncology ICD-O-3 1 Basic Concepts Primary Site/Topography Histology/Morphology Behavior Grade/Immunophenotype 2 ICD-O 3 Structure/Format

More information

ICD-O-3 UPDATES - PENDING

ICD-O-3 UPDATES - PENDING ICD-O-3 UPDATES - PENDING FCDS Annual Meeting July 26, 2013 Sunrise, Florida Steven Peace, CTR ICD-O-3 Work Group ICD-O-3 WORK GROUP Name April Fritz, CTR Lynn Ries, MS Lois Dickie, CTR Linda Mulvihill,

More information

ICD-O-3 UPDATES - PENDING

ICD-O-3 UPDATES - PENDING ICD-O-3 UPDATES - PENDING FCDS Annual Meeting July 26, 2013 Sunrise, Florida Steven Peace, CTR ICD-O-3 Work Group ICD-O-3 WORK GROUP Name April Fritz, CTR Lynn Ries, MS Lois Dickie, CTR Linda Mulvihill,

More information

2018 Grade PEGGY ADAMO, RHIT, CTR OCTOBER 11, 2018

2018 Grade PEGGY ADAMO, RHIT, CTR OCTOBER 11, 2018 1 2018 Grade PEGGY ADAMO, RHIT, CTR ADAMOM@MAIL.NIH.GOV OCTOBER 11, 2018 2 Acknowledgements Donna Hansen, CCR Jennifer Ruhl, NCI SEER Introduction 3 Histologic Type vs. Grade Credit: Dr. Kay Washington

More information

Appendix H 2018 FCDS Required Site Specific Data Items (SSDIs)

Appendix H 2018 FCDS Required Site Specific Data Items (SSDIs) Below is the short list of Site Specific Data Items (SSDI) Required by FCDS for 2018. The list may be subject to changes. FCDS requires only a subset of the 136 total SSDIs available to be reported as

More information

FCDS Annual Educational Conference Orlando, Florida July 28, Steven Peace, CTR

FCDS Annual Educational Conference Orlando, Florida July 28, Steven Peace, CTR FCDS Annual Educational Conference Orlando, Florida July 28, 2017 Steven Peace, CTR 1 Outline 2018 Transition from CS SSFs to Individual Site Specific Prognostic Factor Fields (SSFs) Locating SSFs in the

More information

Q: In order to use the code 8461/3 (serous surface papillary) for ovary, does it have to say the term "surface" on the path report?

Q: In order to use the code 8461/3 (serous surface papillary) for ovary, does it have to say the term surface on the path report? Q&A Session for Collecting Cancer Data: Ovary Q: In order to use the code 8461/3 (serous surface papillary) for ovary, does it have to say the term "surface" on the path report? A: We reviewed both the

More information

Collaborative Staging

Collaborative Staging Slide 1 Collaborative Staging Site-Specific Instructions Prostate 1 In this presentation, we are going to take a closer look at the collaborative staging data items for the prostate primary site. Because

More information

Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 14

Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 14 Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 14 Contents 14. Neuroendocrine Tumours 161 14.1. Diagnostic algorithm

More information

Testicular Malignancies /8/15

Testicular Malignancies /8/15 Collecting Cancer Data: Testis 2014-2015 NAACCR Webinar Series January 8, 2015 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching

More information

Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence

Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence In 2014, there were 452 new cancer cases diagnosed and or treated at Truman Medical Center- Hospital Hill and an additional

More information

Grade Coding Instructions and Tables

Grade Coding Instructions and Tables Grade Coding Instructions and Tables Effective with Cases Diagnosed 1/1/2018 and Forward DRAFT published April 2018 Editors: Jennifer Ruhl, MSHCA, RHIT, CCS, CTR, NCI SEER Jim Hofferkamp, CTR, NAACCR Elizabeth

More information

Annual Report. Cape Cod Hospital and Falmouth Hospital Regional Cancer Network Expert physicians. Quality hospitals. Superior care.

Annual Report. Cape Cod Hospital and Falmouth Hospital Regional Cancer Network Expert physicians. Quality hospitals. Superior care. Annual Report Cape Cod Hospital and Falmouth Hospital Regional Cancer Network 2013 Expert physicians. Quality hospitals. Superior care. Cape Cod Hospital s Davenport- Mugar Hematology/Oncology Center and

More information

HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011

HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011 HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011 SONGKLANAGARIND HOSPITAL FACULTY OF MEDICINE PRINCE OF SONGKLA UNIVERSITY HATYAI SONGKHLA THAILAND EDITOR PARADEE PRECHAWITTAYAKUL, B.Sc. June, 2013 Songklanagarind

More information

Grade Coding Instructions and Tables

Grade Coding Instructions and Tables Grade Coding Instructions and Tables Effective with Cases Diagnosed 1/1/2018 and Forward Published April 2018 Editors: Jennifer Ruhl, MSHCA, RHIT, CCS, CTR, NCI SEER Jim Hofferkamp, CTR, NAACCR Elizabeth

More information

Checklist; Anus: Excisional Biopsy Anus: Excisional Biopsy 1/1/ Checklist; Anus: Resection Anus: Resection 1/1/2005

Checklist; Anus: Excisional Biopsy Anus: Excisional Biopsy 1/1/ Checklist; Anus: Resection Anus: Resection 1/1/2005 ChecklistTemplateVersions ChecklistTemplateVersion Ckey OfficialName VisibleText RevisionDate Checklist; Adrenal gland: 16.1000043 Resection Adrenal gland: Checklist; Ampulla of 17.1000043 Vater: Ampullectomy

More information

Change Log V1.3- v1.4

Change Log V1.3- v1.4 Change Log V1.3- v1.4 This document shows the changes that were made to the SSDI manual and the Grade manual for the SEER*RSA version 1.4 release on (Date TBD). SSDI Manual Section: General Instructions

More information

COLON AND RECTUM SOLID TUMOR RULES ABSTRACTORS TRAINING

COLON AND RECTUM SOLID TUMOR RULES ABSTRACTORS TRAINING COLON AND RECTUM SOLID TUMOR RULES ABSTRACTORS TRAINING COLON AND RECTUM SOLID TUMOR RULES Separate sections for: Introduction Changes from 2007 MP/H rules Equivalent Terms Terms that are NOT Equivalent

More information

Coding Pitfalls 9/11/14

Coding Pitfalls 9/11/14 Coding Pitfalls 2013 2014 NAACCR Webinar Series September 11, 2014 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar

More information

CS Tumor Size. GISTStomach. Collaborative Stage for TNM 7 - Revised 01/27/2010 [ Schema ]

CS Tumor Size. GISTStomach. Collaborative Stage for TNM 7 - Revised 01/27/2010 [ Schema ] GISTStomach Collaborative Stage for TNM 7 - Revised 01/27/2010 [ Schema ] CS Tumor Size Note: the specific tumor size as documented in the medical record. If the ONLY information regarding tumor size is

More information

AMERICAN JOINT COMMITTEE ON CANCER AJCC CANCER STAGING

AMERICAN JOINT COMMITTEE ON CANCER AJCC CANCER STAGING AMERICAN JOINT COMMITTEE ON CANCER AJCC CANCER STAGING ATLAS EDITORS FREDERICK L. GREENE, m.d. Chair, Department of General Surgery Carolinas Medical Center Charlotte, North Carolina CAROLYN C. COMPTON,

More information

Outcomes Report: Accountability Measures and Quality Improvements

Outcomes Report: Accountability Measures and Quality Improvements Outcomes Report: Accountability Measures and Quality Improvements The s Cancer Committee ensures that patients with cancer are treated according to the nationally accepted measures. Because we are an accredited

More information

Grade Coding Instructions and Tables

Grade Coding Instructions and Tables Grade Coding Instructions and Tables Effective with Cases Diagnosed 1/1/2018 and Forward DRAFT published February 2018 Editors: Jennifer Ruhl, MSHCA, RHIT, CCS, CTR, NCI SEER Jim Hofferkamp, CTR, NAACCR

More information

Early Cancer Care FAQ

Early Cancer Care FAQ If you need more information, you can call 6722 2293 (Mon-Fri, 9am-5pm), email our Financial Protection Specialists at financial2@ocbc.com or visit any of our OCBC branches. Q1. What is this Early Cancer

More information

Esophagus, Esophagus GE Junction, Stomach

Esophagus, Esophagus GE Junction, Stomach Esophagus, Esophagus GE Junction, Stomach Education and Training Team Collaborative Stage Data Collection System Version v02.03 Learning Objectives Understand rationale behind changes and updates Understand

More information

S2 File. Clinical Classifications Software (CCS). The CCS is a

S2 File. Clinical Classifications Software (CCS). The CCS is a S2 File. Clinical Classifications Software (CCS). The CCS is a diagnosis categorization scheme based on the ICD-9-CM that aggregates all diagnosis codes into 262 mutually exclusive, clinically homogeneous

More information

A Practicum Approach to CS: GU Prostate, Testis, Bladder, Kidney, Renal Pelvis. Jennifer Ruhl, RHIT, CCS, CTR Janet Stengel, RHIA, CTR

A Practicum Approach to CS: GU Prostate, Testis, Bladder, Kidney, Renal Pelvis. Jennifer Ruhl, RHIT, CCS, CTR Janet Stengel, RHIA, CTR A Practicum Approach to CS: GU Prostate, Testis, Bladder, Kidney, Renal Pelvis Jennifer Ruhl, RHIT, CCS, CTR Janet Stengel, RHIA, CTR Survey Questions and Answers 250 Responses 2 Question #1 A gentleman

More information

Epidemiology in Texas 2006 Annual Report. Cancer

Epidemiology in Texas 2006 Annual Report. Cancer Epidemiology in Texas 2006 Annual Report Cancer Epidemiology in Texas 2006 Annual Report Page 94 Cancer Incidence and Mortality in Texas, 2000-2004 The Texas Department of State Health Services Texas Cancer

More information

Tumor Immunology. Tumor (latin) = swelling

Tumor Immunology. Tumor (latin) = swelling Tumor Immunology Tumor (latin) = swelling benign tumor malignant tumor Tumor immunology : the study of the types of antigens that are expressed by tumors how the immune system recognizes and responds to

More information

Original Article. Cancer December 1,

Original Article. Cancer December 1, Analysis of Stage and Clinical/Prognostic Factors for Colon and Rectal Cancer From SEER Registries: AJCC and Collaborative Stage Data Collection System Vivien W. Chen, PhD 1 ; Mei-Chin Hsieh, MSPH 1 ;

More information

INFORMATION TOPIC: II-5 OR DEMONSTRATION: II-5. DOSAGE, MEASUREMENTS, AND DRUG FORMS (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO:

INFORMATION TOPIC: II-5 OR DEMONSTRATION: II-5. DOSAGE, MEASUREMENTS, AND DRUG FORMS (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO: LESSON PLAN: 5 COURSE TITLE: UNIT: II MEDICATION TECHNICIAN GENERAL PRINCIPLES SCOPE OF UNIT: This unit includes medication terminology, dosage, measurements, drug forms, transcribing physician s orders,

More information

NAACCR Webinar 2018 SeriesImplementations and Timelines

NAACCR Webinar 2018 SeriesImplementations and Timelines NAACCR 2015-2016 Webinar 2018 SeriesImplementations and Timelines August 8, 2017 Session 1 Q&A Please submit all questions concerning webinar content through the Q&A panel. A recording of today s session,

More information

CDC & Florida DOH Attribution

CDC & Florida DOH Attribution FCDS Annual Educational Conference Tampa, Florida July 19, 2018 Steven Peace, CTR 1 CDC & Florida DOH Attribution We acknowledge the Centers for Disease Control and Prevention, for its support of the Florida

More information

ADVANCED ASSESSMENT Medical Math

ADVANCED ASSESSMENT Medical Math ONTARIO BASE HOSPITAL GROUP ADVANCED ASSESSMENT Medical Math 2007 Ontario Base Hospital Group ADVANCED ASSESSMENT Medical Math AUTHOR Tim Dodd AEMCA, ACP Hamilton Base Hospital REVIEWERS/CONTRIBUTORS Rob

More information

UK CAA Oncology Certification Charts

UK CAA Oncology Certification Charts UK CAA Oncology Certification Charts 1. Colorectal 2. Malignant Melanoma 3. Germ Cell Tumour of Testis 4. Renal Cell Carcinoma 5. Breast Carcinoma 6. Non-small Cell Lung Cancer Note: All Class 1 cases

More information

American Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013

American Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013 American Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013 All ages Younger than 45 45 and Older Younger than 65 65 and Older All sites, men 306,920 9,370 297,550 95,980 210,940 All sites,

More information

A Time- and Resource-Efficient Method for Annually Auditing All Reporting Hospitals in Your State: the Inpatient & Outpatient Hospital Discharge Files

A Time- and Resource-Efficient Method for Annually Auditing All Reporting Hospitals in Your State: the Inpatient & Outpatient Hospital Discharge Files A Time- and Resource-Efficient Method for Annually Auditing All Reporting Hospitals in Your State: the Inpatient & Outpatient Hospital Discharge Files By Dr. Martin A. Whiteside Director, Office of Cancer

More information

Collaborative Stage for TNM 7 - Revised 07/14/2009 [ Schema ]

Collaborative Stage for TNM 7 - Revised 07/14/2009 [ Schema ] MelanomaSkin CS Tumor Size Collaborative Stage for TNM 7 - Revised 07/14/2009 [ Schema ] Code 000 No mass/tumor found Description 001-988 001-988 millimeters (code exact size in millimeters) 989 989 millimeters

More information

Cancer Association of South Africa (CANSA)

Cancer Association of South Africa (CANSA) Cancer Association of South Africa (CANSA) Fact Sheet on ICD-10 Coding of Neoplasms Introduction The International Statistical Classification of Diseases and Related Health Problems, 10 th Revision (ICD-10)

More information

Neuroendocrine Tumors

Neuroendocrine Tumors Neuroendocrine Tumors FCDS Annual Conference Boca Raton Marriott at Boca Center July 28, 2016 Steven Peace, BS, CTR Anatomy and Physiology of the (Neuro)Endocrine System WHO Classification, Tumor Grade

More information

Data Harmonization Efforts Across the Cancer Staging System. Donna M. Gress, RHIT, CTR AJCC Technical Specialist

Data Harmonization Efforts Across the Cancer Staging System. Donna M. Gress, RHIT, CTR AJCC Technical Specialist Data Harmonization Efforts Across the Cancer Staging System Donna M. Gress, RHIT, CTR AJCC Technical Specialist Objectives Describe efforts underway to harmonize data elements and concepts used in cancer

More information

2018 SEER Solid Tumor Manual 2018 KCR SPRING TRAINING

2018 SEER Solid Tumor Manual 2018 KCR SPRING TRAINING 2018 SEER Solid Tumor Manual 2018 KCR SPRING TRAINING Eight Groups are Revised for 2018 Head & Neck Colon (includes rectosigmoid and rectum for cases diagnosed 1/1/2018 forward) Lung (2018 Draft not yet

More information

A patient s guide to understanding. Cancer. Screening

A patient s guide to understanding. Cancer. Screening A patient s guide to understanding Cancer Screening Contents 04 06 10 12 Cancer Screening Who Should Go For Cancer Screening 05 Nasopharyngeal Carcinoma Colorectal Cancer 08 Lung Cancer Liver Cancer Breast

More information

The European Commission s science and knowledge service. Joint Research Centre

The European Commission s science and knowledge service. Joint Research Centre The European Commission s science and knowledge service Joint Research Centre Coding Primary Site and Tumour Morphology JRC-ENCR training course Copenhagen, 25 September 2018 Nadya Dimitrova Outline What

More information

Metastatic esophageal cancer icd 10 code

Metastatic esophageal cancer icd 10 code Metastatic esophageal cancer icd 10 code Gogamz Menu Taxanes are conventional treatment for metastatic breast cancer (MBC); however, the solvents (e.g., ethanol and polyoxyethylated castor oil) employed

More information

NET / GIST / MEN. 2014/2015 FCDS Educational Webcast Series. October 16, Steven Peace, CTR

NET / GIST / MEN. 2014/2015 FCDS Educational Webcast Series. October 16, Steven Peace, CTR NET / GIST / MEN 2014/2015 FCDS Educational Webcast Series October 16, 2014 Steven Peace, CTR Anatomy and Physiology of the (Neuro)Endocrine System WHO Classification, Tumor Grade, Hereditary Syndromes

More information

CRITICAL ANALYSIS OF NEN GUIDELINES. G Pentheroudakis Associate Professsor of Oncology Medical School, University of Ioannina Chair, ESMO Guidelines

CRITICAL ANALYSIS OF NEN GUIDELINES. G Pentheroudakis Associate Professsor of Oncology Medical School, University of Ioannina Chair, ESMO Guidelines CRITICAL ANALYSIS OF NEN GUIDELINES G Pentheroudakis Associate Professsor of Oncology Medical School, University of Ioannina Chair, ESMO Guidelines DISCLOSURES NO CONFLICTS OF INTEREST TO DECLARE UPDATED

More information

Colon, Rectum, and Appendix

Colon, Rectum, and Appendix Colon, Rectum, and Appendix 2011 Reporting Requirements and CSv02.03.02 NCCN/ASCO Treatment Guidelines by Stage FCDS 2011 Educational Webcast Series September 15, 2011 Steven Peace, CTR Presentation Outline

More information

Colon, Rectum, and Appendix. Presentation Outline. Overview Tumor Characteristics

Colon, Rectum, and Appendix. Presentation Outline. Overview Tumor Characteristics Colon, Rectum, and Appendix 2011 Reporting Requirements and CSv02.03.02 NCCN/ASCO Treatment Guidelines by Stage FCDS 2011 Educational Webcast Series September 15, 2011 Steven Peace, CTR Presentation Outline

More information

Clinical Biochemistry Department City Hospital

Clinical Biochemistry Department City Hospital Cancer Biochemistry and Tumour Markers Clinical Biochemistry Department City Hospital In this lecture Cancer basics Definition of Tumour Marker (TM) What is the perfect TM? History of TMs Examples of TMs

More information

A. Incorrect! The esophagus connects the pharynx and the stomach.

A. Incorrect! The esophagus connects the pharynx and the stomach. Human Physiology - Problem Drill 19: Digestive Physiology and Nutrition Question No. 1 of 10 Instructions: (1) Read the problem and answer choices carefully, (2) Work the problems on paper as 1. This organ

More information

Pancreas Quizzes c. Both A and B a. Directly into the blood stream (not using ducts)

Pancreas Quizzes c. Both A and B a. Directly into the blood stream (not using ducts) Pancreas Quizzes Quiz 1 1. The pancreas produces hormones. Which type of hormone producing organ is the pancreas? a. Endocrine b. Exocrine c. Both A and B d. Neither A or B 2. Endocrine indicates hormones

More information

INFORMATION TOPIC: II-5 OR DEMONSTRATION: II-5. DOSAGE, MEASUREMENTS, AND DRUG FORMS (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO:

INFORMATION TOPIC: II-5 OR DEMONSTRATION: II-5. DOSAGE, MEASUREMENTS, AND DRUG FORMS (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO: LESSON PLAN: 5 COURSE TITLE: UNIT: II MEDICATION TECHNICIAN GENERAL PRINCIPLES SCOPE OF UNIT: This unit includes medication terminology, dosage, measurements, drug forms, transcribing physician s orders,

More information

CS Release Notes Version ORGANIZATION OF RELEASE NOTES

CS Release Notes Version ORGANIZATION OF RELEASE NOTES ORGANIZATION OF RELEASE NOTES The Release Notes are organized in the following manner: Manual Review for Recoding of Cases : General Coding Instructions Part I Section 2: Lab Tests, Tumor Markers, and

More information

MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site

MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site POLICY: PG0364 ORIGINAL EFFECTIVE: 04/22/16 LAST REVIEW: 07/26/18 MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site GUIDELINES This policy does not certify benefits or authorization

More information

Automated Coding of Key Case Identifiers from Text-Based Electronic Pathology Reports

Automated Coding of Key Case Identifiers from Text-Based Electronic Pathology Reports Automated Coding of Key Case Identifiers from Text-Based Electronic Pathology Reports George Cernile Artificial Intelligence in Medicine, Inc NAACCR 2017 Conference Albuquerque New Mexico, USA June 22,

More information

7/29/ Education & Training Plan FCDS Webcast Series and VoIP Audio. Outline Education & Training Plan

7/29/ Education & Training Plan FCDS Webcast Series and VoIP Audio. Outline Education & Training Plan 2014-2015 Education & Training Plan FCDS Webcast Series and VoIP Audio 1 2 0 1 4-2 0 1 5 F C D S E D U C A T I O N & T R A I N I N G P L A N T R A I N I N G T O O L S A N D R E S O U R C E S G O T O M

More information

PANCREAS DUCTAL ADENOCARCINOMA PDAC

PANCREAS DUCTAL ADENOCARCINOMA PDAC CONTENTS PANCREAS DUCTAL ADENOCARCINOMA PDAC I. What is the pancreas? II. III. IV. What is pancreas cancer? What is the epidemiology of Pancreatic Ductal Adenocarcinoma (PDAC)? What are the risk factors

More information

Fast, automated, precise

Fast, automated, precise Thermo Scientific B R A H M S / NSE Immunodiagnostic Assays Fast, automated, precise Neuroendocrine tumor markers on KRYPTOR Systems First and only fully automated CgA assay worldwide Shortest time to

More information